# Drägerwerk Reports Q3 EBIT of €48 Million and Reaffirms 2026 Outlook

- URL: https://stocks.freetheai.org/news/dragerwerk-reports-q3-ebit-of-48-million-and-reaffirms-2026-outlook-d580aa
- Published: 2026-10-14T17:32:03Z
- Category: earnings; sentiment: mixed; impact: medium
- Symbols: [XETR:DRW8](https://stocks.freetheai.org/symbols/XETR-DRW8)
- Written by our AI from expert market sources across the web for FreeTheAI Stocks, built by Vibhek Soni
- How write-ups are made: https://stocks.freetheai.org/how-we-write
- Not financial advice: https://stocks.freetheai.org/disclaimer

Drägerwerk AG & Co. KGaA (XETR:DRW8) reported preliminary third-quarter 2026 earnings before interest and taxes of approximately 48 million euros, compared with 56.7 million euros in the same period a year earlier. Operating profit for the quarter included 20.1 million euros from customs refunds. Net sales totaled roughly 851 million euros, up 1% on a currency-adjusted basis. Shares of the company traded down 2.81% at 89.8 EUR following the update.

The decline in operating profit highlights ongoing margin pressure, even as gross margin improved to approximately 47.5% from 45.6% a year ago. Demand remained strong, with currency-adjusted order intake rising 7% to around 926 million euros, helping expand the company's backlog.

Looking ahead, management reaffirmed its full-year 2026 outlook. The company continues to project net sales growth between 2% and 6% on a currency-adjusted basis and an EBIT margin of 6% to 8%.

## Key points

- Preliminary Q3 2026 EBIT was about 48 million euros, down from 56.7 million euros in the prior year.
- Results included 20.1 million euros in one-off customs refunds.
- Net sales grew 1% currency-adjusted to roughly 851 million euros.
- Order intake climbed 7% currency-adjusted to about 926 million euros.
- Full-year 2026 guidance was confirmed for 2% to 6% sales growth and a 6% to 8% EBIT margin.

## Questions and answers

### What were Drägerwerk's Q3 2026 financial results?

Drägerwerk reported preliminary Q3 2026 EBIT of about 48 million euros, down from 56.7 million euros last year, including 20.1 million euros in customs refunds. Net sales reached approximately 851 million euros.

### What is Drägerwerk's outlook for full-year 2026?

Drägerwerk reaffirmed its 2026 guidance, continuing to expect currency-adjusted sales growth of 2% to 6% and an EBIT margin between 6% and 8%.

### How did Drägerwerk's order intake perform in Q3 2026?

Currency-adjusted order intake increased 7% year-over-year to approximately 926 million euros in the third quarter.